Group One Trading’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Hold
0
2578
2025
Q1
Sell
-8,728
Closed -$14.4K 2511
2024
Q4
$14.4K Buy
8,728
+6,611
+312% +$10.9K ﹤0.01% 1475
2024
Q3
$7.41K Buy
+2,117
New +$7.41K ﹤0.01% 1317
2024
Q2
Sell
-1,050
Closed -$7.71K 2220
2024
Q1
$7.71K Sell
1,050
-15,639
-94% -$115K ﹤0.01% 1325
2023
Q4
$62.4K Buy
16,689
+10,400
+165% +$38.9K ﹤0.01% 1025
2023
Q3
$13.3K Buy
+6,289
New +$13.3K ﹤0.01% 1353
2023
Q2
Hold
0
2302
2023
Q1
Sell
-2,654
Closed -$26.8K 2300
2022
Q4
$26.8K Buy
2,654
+419
+19% +$4.23K ﹤0.01% 1243
2022
Q3
$50K Sell
2,235
-9,201
-80% -$206K ﹤0.01% 1233
2022
Q2
$283K Buy
11,436
+5,200
+83% +$129K ﹤0.01% 772
2022
Q1
$242K Buy
+6,236
New +$242K ﹤0.01% 970
2021
Q4
Hold
0
2538
2021
Q3
Sell
-5,427
Closed -$471K 2434
2021
Q2
$471K Buy
+5,427
New +$471K ﹤0.01% 835
2021
Q1
Hold
0
2173
2020
Q4
Sell
-1,691
Closed -$68K 1980
2020
Q3
$68K Sell
1,691
-5,373
-76% -$216K ﹤0.01% 1022
2020
Q2
$242K Sell
7,064
-19,258
-73% -$660K ﹤0.01% 595
2020
Q1
$585K Buy
26,322
+23,730
+916% +$527K ﹤0.01% 329
2019
Q4
$51K Buy
2,592
+2,328
+882% +$45.8K ﹤0.01% 906
2019
Q3
$4K Sell
264
-1,200
-82% -$18.2K ﹤0.01% 1172
2019
Q2
$30K Sell
1,464
-2,900
-66% -$59.4K ﹤0.01% 903
2019
Q1
$77K Sell
4,364
-3,361
-44% -$59.3K ﹤0.01% 679
2018
Q4
$99K Buy
+7,725
New +$99K ﹤0.01% 741
2018
Q3
Sell
-23,312
Closed -$264K 1621
2018
Q2
$264K Buy
+23,312
New +$264K ﹤0.01% 574
2018
Q1
Hold
0
1502
2017
Q4
Hold
0
1538